The company behind Mounjaro: what you should know about tirzepatide's maker

The myth worth correcting: Mounjaro isn't made by multiple companies

A common assumption online is that tirzepatide comes from several manufacturers or that generic versions are already available in the UK. Neither is true. Eli Lilly holds the marketing authorisation for Mounjaro in the UK, and tirzepatide is produced exclusively under Lilly's name. If you encounter a listing for "generic tirzepatide" or a product that looks like Mounjaro but isn't labelled as such, that is a serious red flag. The MHRA has warned publicly about counterfeit weight-loss pens, and any product sold without a valid prescription and a verifiable supply chain should be avoided. For more on what to look for when buying online, our guide to buying Mounjaro online safely walks through the key checks.

Lilly's UK supply chain matters in a practical way: it means every genuine Mounjaro KwikPen delivered through a regulated pharmacy can be traced back to an authorised manufacturer. That traceability disappears the moment you step outside the licensed route.

What Eli Lilly actually created with tirzepatide

Lilly's researchers developed tirzepatide as a single molecule that activates two gut-hormone receptors simultaneously: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). Other weight-loss injectables on the UK market target only GLP-1. The dual action slows gastric emptying, reduces appetite and affects energy regulation through a slightly different mechanism than single-agonist medicines. This distinction matters clinically and is one reason NICE, in its appraisal of tirzepatide (TA1026, published December 2024), considered it separately from existing GLP-1 therapies. You can read more about how the medicine itself works on our tirzepatide overview page.

The SURMOUNT-1 trial, which enrolled over 2,500 adults with obesity and no diabetes, reported average body-weight reductions of around 20–21% at the highest dose over 72 weeks. Lilly ran a broad clinical programme across diabetes (SURPASS) and weight management (SURMOUNT) involving more than 10,000 participants in total.

Lilly's role in pricing and UK availability

Understanding which company makes Mounjaro also helps explain pricing. Eli Lilly sets the list price at which it supplies to the licensed UK wholesale chain, and that price changed significantly from 1 September 2025: the highest-dose pen's list price rose from around £122 to around £330. Private providers, including regulated online pharmacies, source stock from that same authorised chain and set their own consultation and service fees on top. If you want to understand the full cost picture, our Mounjaro treatment page explains what's included in private pricing. Lilly also raised UK supply in stages through 2024 and 2025 to address demand, so stock availability is now generally more stable than it was at launch.

As Mounjaro's sole manufacturer, Lilly also owns the patent and bears responsibility for post-market safety surveillance. The medicine's Black Triangle status means Lilly and the MHRA actively collect safety data from prescribers and patients; if you experience a side effect, it can be reported via the MHRA's Yellow Card scheme.

What this means if you're considering treatment

Knowing that a single, well-established company manufactures Mounjaro under MHRA oversight is reassuring context, but it doesn't change the clinical requirement: tirzepatide remains a prescription-only medicine regardless of where you read about it. A prescriber assesses your BMI, health history and current medicines before deciding whether it's appropriate for you. Adults with a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure or type 2 diabetes, may meet the licensed criteria, though BMI alone is never the whole picture. For a plain-English summary of the licensed uses of Mounjaro, including the conditions it's approved to treat, that page covers the detail. If you'd like to understand what company makes Mounjaro and how that affects which route of supply is considered legitimate, our clinical team at nume reviews every consultation the same day. Check your eligibility by starting a free consultation with our prescribers.